Cargando…

Population Impact & Efficiency of Benefit‐Targeted Versus Risk‐Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease

BACKGROUND: Benefit‐targeted statin prescribing may be superior to risk‐targeted statin prescribing (the current standard), but the impact and efficiency of this approach are unclear. METHODS AND RESULTS: We analyzed the National Health and Nutrition Examination Survey (NHANES) using an open‐source...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pletcher, Mark J., Pignone, Michael, Jarmul, Jamie A., Moran, Andrew E., Vittinghoff, Eric, Newman, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523747/ https://www.ncbi.nlm.nih.gov/pubmed/28188251 http://dx.doi.org/10.1161/JAHA.116.004316

Ejemplares similares

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
por: Fleetcroft, Robert, et al.
Publicado: (2014)

Young Adult Exposure to Cardiovascular Risk Factors and Risk of Events Later in Life: The Framingham Offspring Study
por: Pletcher, Mark J., et al.
Publicado: (2016)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia
por: Demoz, Gebre Teklemariam, et al.
Publicado: (2019)

Risk‐benefit analysis of use of statins for primary prevention of cardiovascular disease in subjects without diabetes
por: Chan, Juliana CN
Publicado: (2013)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention()
por: Wang, Frances M., et al.
Publicado: (2023)

Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis
por: Keller, Heidemarie, et al.
Publicado: (2013)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
por: Dorsch, Michael P., et al.
Publicado: (2019)

Factors predicting statin prescribing for primary prevention: a historical cohort study
por: Finnikin, Samuel, et al.
Publicado: (2021)

Survival Benefits of Statins for Primary Prevention: A Cohort Study
por: Gitsels, Lisanne A., et al.
Publicado: (2016)

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study
por: Yebyo, Henock G., et al.
Publicado: (2019)

Retrospective cohort study of statin prescribing for primary prevention among people living with HIV
por: Nardolillo, Joseph A, et al.
Publicado: (2021)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
por: Saadati, Hassan, et al.
Publicado: (2020)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
por: Ryou, In Sun, et al.
Publicado: (2022)

Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age
por: Kim, Kyungmann, et al.
Publicado: (2021)

Benefits of statin therapy and compliance in high risk cardiovascular patients
por: Lardizabal, Joel A, et al.
Publicado: (2010)

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
por: Yebyo, Henock G., et al.
Publicado: (2018)

Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
por: Koo, Bo Kyung
Publicado: (2014)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

The Prevalence of Potential Prescribing Omissions for Antiplatelets and Statins in Older Adults With Atherosclerotic Cardiovascular Disease
por: Alshehri, Samah, et al.
Publicado: (2023)

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
por: Yebyo, Henock G., et al.
Publicado: (2020)

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
por: Kumar, Arun H. S.
Publicado: (2016)

Primary prevention with statins in cardiovascular diseases: A Saudi Arabian perspective
por: Mahmood, D., et al.
Publicado: (2015)

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
por: Hope, Holly F., et al.
Publicado: (2019)

Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients
por: Strandberg, Timo E.
Publicado: (2019)

Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
por: Coste, Joël, et al.
Publicado: (2019)

Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic
por: Malo, Sara, et al.
Publicado: (2022)

Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
por: Kohli-Lynch, Ciaran N., et al.
Publicado: (2022)

TARGET antibiotics – prescribing in primary care
Publicado: (2020)

Factors Associated with the Prescribing of High-Intensity Statins
por: Chaure-Pardos, Armando, et al.
Publicado: (2020)

Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care
por: Pate, Alexander, et al.
Publicado: (2020)

Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular Benefit
por: McTaggart, Fergus, et al.
Publicado: (2008)

Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention
por: Feenstra, Talitha L, et al.
Publicado: (2011)

Coronary heart disease and ischemic stroke polygenic risk scores and atherosclerotic cardiovascular disease in a diverse, population-based cohort study
por: Bebo, Allison, et al.
Publicado: (2023)

Price versus clinical guidelines in primary care statin prescribing: a retrospective cohort study and cost simulation model
por: De Zarate, Matias Ortiz, et al.
Publicado: (2021)

To JUPITER and beyond: Statins, inflammation, and primary prevention
por: Rao, Ajay D, et al.
Publicado: (2010)

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Statins: benefits and risks revisited
por: Balaz, Miroslav, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ki423rj1iokrb47gcjf0fshcg